Dr. Wysham goes over the details of how the new SGLT2 compounds work, and talks about the benefits and disadvantages of these potential new agents, including previous concerns around bladder cancer with dapagliflozin, giving us an update on the latest news. More videos with Dr. Wysham: Dr. Carol Wysham, Introduction …

Dr. Wysham tells us about her anticipation of the results of two specific trials, one a study on an old-fashioned remedy called salsalate, and then the ORIGIN trial results which looked at the effects on cardiovascular disease with early intervention with insulin.  More videos with Dr. Wysham: Dr. Carol Wysham, …